Aaron J. Trask, PhD :: Nationwide Children's Hospital, Columbus, Ohio

Aaron J. Trask, PhD

Aaron J. Trask, PhD

Center for Cardiovascular Research
Principal Investigator

Contact Information

The Research Institute
WB4135, 700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 355-5760
FX: (614) 355-5725
Email Me

Biography

Aaron J. Trask, PhD, FAHA, is a Principal Investigator in the Center for Cardiovascular and Pulmonary Research at Nationwide Children's Hospital and an Assistant Professor (Tenure Track) in the Department of Pediatrics at The Ohio State University College of Medicine. He trained as a physiologist and pharmacologist at Wake Forest University and completed his postdoctoral training in cardiovascular physiology at Nationwide Children's Hospital.

Dr. Trask's research focuses on studying processes involved in adverse micro- and macro-vascular remodeling in disease, including early type 2 diabetes and metabolic syndrome.

View CV »

Gender:

  • Male

Languages Spoken:

  • English

Research Interests

Research Center:

Areas of Interest:

  • Heart disease in type 2 diabetes mellitus (T2DM) directly correlates with the severity of coronary artery disease (CAD), which results in impaired coronary flow and increased risk of myocardial infarction (MI). While atherosclerosis in large coronary arteries (macrovessels) and endothelial dysfunction are known contributors to MI, the influence of coronary resistance microvessel (CRM) remodeling versus macrovessel remodeling to T2DM-induced cardiac disease remains largely unknown. Therefore, the over-arching goal of Dr. Trask's research program is to understand how early fundamental differences in large arteries and CRMs (main determinants of blood flow and perfusion) contribute to end-organ complications in T2DM and metabolic syndrome. This area of research has important clinical significance, since nearly all current therapeutic approaches target large arteries with little respect to CRMs.

Research Funding*:

  • NIH/NHLBI K99/R00 Pathway to Independence Award: Differential Macro- and Micro-Vascular Remodeling in Type 2 Diabetes and Metabolic Syndrome. 6/1/2014-5/31/2019.
    Role: PI
  • Institutional Funds:Funds intended to help start laboratory during transition from mentored junior faculty to independent junior faculty. 7/15/2014-7/14/2019.
    Role: PI
  • Heart Center Research Pilot: Mechanisms of Restenosis of Ductus Arteriosus in Patients Undergoing Complex Cardiac Surgery. 5/1/2014-12/31/2015.
    Role: PI
  • American Heart Association Grant: Matrix Stiffness and Cardiac Fibroblast Phenotype. 7/1/2015-6/30/2017.
    Role: Co-Investigator
  • American Heart Association Scientist Development Grant: Differential Macro- and Micro-Vascular Remodeling in Type 2 Diabetes. Total Award Amount: $308,000. 7/1/2013-5/31/2014.
    Role: PI
    Remainder of award was relinquished due to overlap with NIH K99/R00
  • Training in Congenital and Acquired Heart Disease: AGE/RAGE Associated Coronary Artery Remodeling in Type 2 Diabetes. 1/1/2010 – 6/30/2012
    Role: Postdoctoral Fellow

Education and Training

Undergraduate School

  • Ohio Northern University
    Date Completed: 05/01/2003

Graduate School

  • Wake Forest University
    Date Completed: 12/31/2008

Post Doctoral

  • The Research Institute at Nationwide Children's Hospital
    Date Completed: 06/30/2013

Date of Appointment at Nationwide Children’s Hospital:

  • 07/01/2013

Professional Experience

2016–present

  • Member, Graduate Faculty, Biomedical Engineering Graduate Program, The Ohio State University

2016–present

  • Adjunct Assistant Professor, Department of Physiology and Cell Biology, The Ohio State University College of Medicine

2016–present

  • Assistant Professor (Tenure Track), Department of Pediatrics, The Ohio State University College of Medicine

2015–present

  • Member, Graduate Faculty, Integrated Biomedical Science Graduate Program, The Ohio State University

2015–present

  • Investigator, Dorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center

2013–present

  • Principal Investigator, Center for Cardiovascular and Pulmonary Research and The Heart Center, The Research Institute at Nationwide Children’s Hospital

2013–2016

  • Research Assistant Professor, Department of Pediatrics, The Ohio State University College of Medicine

Publications

  • 2016. Maternal high fat diet exposure is associated with increased hepcidin levels, decreased myelination, and neurobehavioral changes in male offspring.  BRAIN BEHAVIOR AND IMMUNITY. Vol. 58, no. November 1.
  • 2016. Enhanced steatosis and fibrosis in liver of adult offspring exposed to maternal high-fat diet.  Gene Expression. Vol. 17, no. 1. (January 1).
  • 2016. The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice.  VASCULAR PHARMACOLOGY. Vol. 76, no. January 1.
  • 2015. Vascular Mechanics in Decellularized Aortas and Coronary Resistance Microvessels in Type 2 Diabetic db/db Mice.  ANNALS OF BIOMEDICAL ENGINEERING. Vol. 43, no. 11. (November 1).
  • 2015. MicroRNA miR145 Regulates TGFBR2 Expression and Matrix Synthesis in Vascular Smooth Muscle Cells.  CIRCULATION RESEARCH. Vol. 116, no. 1. (January 2).
  • 2014. Effects of a myofilament calcium sensitizer on left ventricular systolic and diastolic function in rats with volume overload heart failure.  AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. Vol. 307, no. 11. (December 1).
  • 2014. The diabetic vasculature: Physiological mechanisms of dysfunction and influence of aerobic exercise training in animal models.  LIFE SCIENCES. Vol. 102, no. 1. (April 25).
  • 2013. Angiotensin II and mitochondrial-derived oxidative stress play a role in coronary arteriole remodeling in type 2 diabetes.  FASEB JOURNAL. Vol. 27, no. April 1.
  • Lewis,Kristin; Guggilam,Anuradha; Trask,Aaron,J; Cismowski,Mary,J; Lucchesi,Pamela,A. 2013. The myofilament Ca2+sensitizer levosimendan maintains systolic function in volume overload heart failure in rats.  FASEB JOURNAL. Vol. 27, no. April.
  • 2013. The myofilament Ca2+sensitizer levosimendan maintains systolic function in volume overload heart failure in rats.  FASEB JOURNAL. Vol. 27, no. April 1.
  • 2013. Proteomic analysis of aortic and coronary resistance microvessel tissue in type 2 diabetic db/db mice.  FASEB JOURNAL. Vol. 27, no. April 1.
  • Halleck,Kathryn,Elizabeth; Katz,Paige,S; Dos Santos,Karen,Tiago; Trask,Aaron,J; Lucchesi,Pamela,A. 2013. Angiotensin II and mitochondrial-derived oxidative stress play a role in coronary arteriole remodeling in type 2 diabetes.  FASEB JOURNAL. Vol. 27, no. April.
  • Trask,Aaron,J; Cismowski,Mary,J; Halleck,Kathryn; Lucchesi,Pamela,A. 2013. Proteomic analysis of aortic and coronary resistance microvessel tissue in type 2 diabetic db/db mice.  FASEB JOURNAL. Vol. 27, no. April.
  • Trask,Aaron,J; Delbin,Maria,A; Katz,Paige,S; Zanesco,Angelina; Lucchesi,Pamela,A. 2012. Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: Impact of exercise training.  VASCULAR PHARMACOLOGY. Vol. 57, no. 5-6. (November): 187-193.
  • 2012. Differential coronary resistance microvessel remodeling between type 1 and type 2 diabetic mice: Impact of exercise training.  VASCULAR PHARMACOLOGY. Vol. 57, no. 5-6. (November 1).
  • Trask,Aaron,J; Katz,Paige,S; Kelly,Amy,P; Galantowicz,Maarten,L; Cismowski,Mary,J; West,T,Aaron; Neeb,Zachary,P; Berwick,Zachary,C; Goodwill,Adam,G; Alloosh,Mouhamad; Tune,Johnathan,D; Sturek,Michael; Lucchesi,Pamela,A. 2012. Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome.  JOURNAL OF APPLIED PHYSIOLOGY. Vol. 113, no. 7. (October): 1128-1140.
  • 2012. Dynamic micro- and macrovascular remodeling in coronary circulation of obese Ossabaw pigs with metabolic syndrome.  JOURNAL OF APPLIED PHYSIOLOGY. Vol. 113, no. 7. (October 1).
  • Groban, L., Wang, H., Machado, F. S., Trask, A. J., Kritchevsky, S. B., Ferrario, C. M., Diz, D. I. 2012. Low glial angiotensinogen improves body habitus, diastolic function, and exercise tolerance in aging male rats.  Cardiovasc Endocrinol. Vol. 1, no. 3. (September): 49-58. PubMed ID: 23795309
  • Trask,Aaron,J; Katz,Paige,S; Kelly,Amy,P; Cismowski,Mary,J; Galantowicz,Maarten,L; Neeb,Zachary,P; Alloosh,Mouhamad; Sturek,Michael; Lucchesi,Pamela,A. 2012. Differential Stiffness between Resistance Microvessels and Conduit Arteries in the Coronary Circulation of Ossabaw Swine with Metabolic Syndrome.  FASEB JOURNAL. Vol. 26, no. April.
  • Trask,Aaron,J; Delbin,Maria,A; Katz,Paige,S; Zanesco,Angelina; Lucchesi,Pamela,A. 2012. Aerobic Exercise Training Partially Reverses Inward Hypertrophic Coronary Arteriole Remodeling in Type 2 Diabetic db/db Mice.  FASEB JOURNAL. Vol. 26, no. April.
  • 2012. Differential Stiffness between Resistance Microvessels and Conduit Arteries in the Coronary Circulation of Ossabaw Swine with Metabolic Syndrome.  FASEB JOURNAL. Vol. 26, no. April 1.
  • 2012. Aerobic Exercise Training Partially Reverses Inward Hypertrophic Coronary Arteriole Remodeling in Type 2 Diabetic db/db Mice.  FASEB JOURNAL. Vol. 26, no. April 1.
  • 2012. Low glial angiotensinogen improves body habitus, diastolic function, and exercise tolerance in aging male rats.  Cardiovascular Endocrinology. Vol. 1, no. 3. (January 1).
  • Delbin,Maria,Andreia; Trask,Aaron,J; Cismowski,Mary; Lucchesi,Pamela,A; Zanesco,Angelia. 2011. Aerobic Exercise Training Improves Endothelial Dysfunction in Type 2 Diabetic Mice by Advanced Glycation End Products-Independent Pathway.  FREE RADICAL BIOLOGY AND MEDICINE. Vol. 51, no. November: S61-S61.
  • 2011. Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness.  BASIC RESEARCH IN CARDIOLOGY. Vol. 106, no. 6. (November 1).
  • Delbin,Maria,Andreia; Trask,Aaron,J; Cismowski,Mary; Lucchesi,Pamela,A; Zanesco,Angelia. 2011. Aerobic Exercise Training Improves Endothelial Dysfunction in Type 2 Diabetic Mice by Advanced Glycation End Products-Independent Pathway.  FREE RADICAL BIOLOGY AND MEDICINE. Vol. 51, no. November 1: S61-S61-S61-S61.
  • 2011. Mesenteric Resistance Arteries in Type 2 Diabetic db/db Mice Undergo Outward Remodeling.  PLOS ONE. Vol. 6, no. 8. (August 4).
  • 2011. Histopathologic Evaluation of Patent Ductus Arteriosus Stents After Hybrid Stage I Palliation.  PEDIATRIC CARDIOLOGY. Vol. 32, no. 4. (April 1).
  • Trask,Aaron,J; Katz,Paige,S; Stewart,James,A; Lucchesi,Pamela,A. 2011. Receptor for advanced glycation end products is involved in remodeling of diabetic coronary arterioles.  FASEB JOURNAL. Vol. 25, no. April.
  • 2011. Receptor for advanced glycation end products is involved in remodeling of diabetic coronary arterioles.  FASEB JOURNAL. Vol. 25, no. April 1.
  • Egan, M. J., Trask, A. J., Baker, P. B., Lawrence, J., Ladich, E., Virmani, R., Hill, S. L., Cheatham, J. P., Galantowicz, M., Lucchesi, P. A., Kovalchin, J. P. 2011. Histopathologic evaluation of patent ductus arteriosus stents after hybrid stage I palliation.  Pediatr Cardiol. Vol. 32, no. 4. (January 1): 413-7-413-7. PubMed ID: 21298382
  • Katz, P. S., Trask, A. J., Souza-Smith, F. M., Hutchinson, K. R., Galantowicz, M. L., Lord, K. C., Stewart, J. A., Jr., Cismowski, M. J., Varner, K. J., Lucchesi, P. A. 2011. Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness.  Basic Res Cardiol. Vol. 106, no. 6. (January): 1123-34. PubMed ID: 21744279
  • Souza-Smith, F. M., Katz, P. S., Trask, A. J., Stewart, J. A., Jr., Lord, K. C., Varner, K. J., Vassallo, D. V., Lucchesi, P. A. 2011. Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling.  PLoS One. Vol. 6, no. 8. (January): ee23337. PubMed ID: 21829729
  • Egan, M. J., Trask, A. J., Baker, P. B., Lawrence, J., Ladich, E., Virmani, R., Hill, S. L., Cheatham, J. P., Galantowicz, M., Lucchesi, P. A., Kovalchin, J. P. 2011. Histopathologic evaluation of patent ductus arteriosus stents after hybrid stage I palliation.  Pediatr Cardiol. Vol. 32, no. 4. (January): 413-7. PubMed ID: 21298382
  • 2010. Inhibition of Angiotensin-Converting Enzyme 2 Exacerbates Cardiac Hypertrophy and Fibrosis in Ren-2 Hypertensive Rats.  AMERICAN JOURNAL OF HYPERTENSION. Vol. 23, no. 6. (June 1).
  • 2010. Inward coronary artery microvessel remodeling in Ossabaw swine with metabolic syndrome.  FASEB JOURNAL. Vol. 24, no. April 1.
  • Trask,Aaron,J; Katz,Paige,S; Neeb,Zachary,P; Alloosh,Mouhamad; Sturek,Michael; Lucchesi,Pamela,A. 2010. Inward coronary artery microvessel remodeling in Ossabaw swine with metabolic syndrome.  FASEB JOURNAL. Vol. 24, no. April.
  • Katz,Paige,Shattuck; Trask,Aaron,J; Lucchesi,Pamela,A. 2010. Progressive Coronary Artery Remodeling in Diabetic db/db Mice.  FASEB JOURNAL. Vol. 24, no. April.
  • 2010. Progressive Coronary Artery Remodeling in Diabetic db/db Mice.  FASEB JOURNAL. Vol. 24, no. April 1.
  • Trask, A. J., Groban, L., Westwood, B. M., Varagic, J., Ganten, D., Gallagher, P. E., Chappell, M. C., Ferrario, C. M. 2010. Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats.  Am J Hypertens. Vol. 23, no. 6. (January): 687-93. PubMed ID: 20300067
  • 2009. Inward Coronary Artery Remodeling in Established Type II Diabetic Mice.  HYPERTENSION. Vol. 54, no. 4. (October 1).
  • Trask,Aaron,J; Katz,Paige,S; Lucchesi,Pamela,A. 2009. Inward Coronary Artery Remodeling in Established Type II Diabetic Mice.  HYPERTENSION. Vol. 54, no. 4. (October): E121-E121.
  • Trask AJ, Varagic J, Ahmad S, Ferrario CM. 2009. Angiotensin-(1-7), Angiotensin Converting Enzyme 2, and New Components of the Renin-Angiotensin System. In Renin-Angiotensin System and Cardiovascular Disease. Edited by DeMello WC, Frohlich ED. Totowa: Humana Press.
  • Trask AJ, Varagic J, Ahmad S, Ferrario CM. 2009. Angiotensin-(1-7), Angiotensin Converting Enzyme 2, and New Components of the Renin-Angiotensin System. In Renin-Angiotensin System and Cardiovascular Disease. Edited by DeMello WC, Frohlich ED.
  • Katz,Paige,S; Trask,Aaron,J; Lucchesi,Pamela,A. 2009. Curcuminoids: Spicing up sympathovagal tone.  NUTRITION. Vol. 25, no. 7-8. (July): 879-880.
  • 2009. Curcuminoids: Spicing up sympathovagal tone.  NUTRITION. Vol. 25, no. 7-8. (July 1).
  • 2009. Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy.  AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. Vol. 296, no. 4. (April 1).
  • Ferrario, C. M., Varagic, J., Habibi, J., Nagata, S., Kato, J., Chappell, M. C., Trask, A. J., Kitamura, K., Whaley-Connell, A., Sowers, J. R. 2009. Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy.  Am J Physiol Heart Circ Physiol. Vol. 296, no. 4. (January): H1184-92. PubMed ID: 19218503
  • Katz, P. S., Trask, A. J., Lucchesi, P. A. 2009. Curcuminoids: Spicing up sympathovagal tone.  Nutrition. Vol. 25, no. 7-8. (January): 879-80. PubMed ID: 19539177
  • Trask AJ, Ferrario CM. 2009. The Renin-Angiotensin System and the Heart. In Textbook of Nephro-Endocrinology. Edited by Singh A, Williams G. San Diego: Elsevier.
  • Katz, P. S., Trask, A. J., Lucchesi, P. A. 2009. Curcuminoids: Spicing up sympathovagal tone.  Nutrition. Vol. 25, no. 7-8. (January 1): 879-80-879-80. PubMed ID: 19539177
  • 2008. The Renin-Angiotensin System and the Heart. In Textbook of Nephro-Endocrinology.
  • Ferrario,Carlos,M; Varagic,Jasmina; Chappell,Mark,C; Trask,Aaron,J; Nagata,Sayaka; Kato,Johji. 2008. Bilateral nephrectomy augments the cardiac content of angiotensin-(1-12) and angiotensin I in Wistar Kyoto rats.  HYPERTENSION. Vol. 52, no. 4. (October): E126-E126.
  • Trask,Aaron,J; Jessup,Jewell,A; Tallant,E,A; Chappell,Mark,C; Ferrario,Carlos,M. 2008. Renin-independent processing of angiotensin-(1-12) in the rat heart and isolated myocytes.  HYPERTENSION. Vol. 52, no. 4. (October): E45-E46.
  • 2008. Inhibition of angiotensin-converting enzyme 2 aggravates cardiac hypertrophy in Ren-2 hypertensive rats.  HYPERTENSION. Vol. 52, no. 4. (October 1).
  • Trask,Aaron,J; Groban,Leanne; Varagic,Jasmina; Ferrario,Carlos,M. 2008. Inhibition of angiotensin-converting enzyme 2 aggravates cardiac hypertrophy in Ren-2 hypertensive rats.  HYPERTENSION. Vol. 52, no. 4. (October): E126-E126.
  • 2008. Bilateral nephrectomy augments the cardiac content of angiotensin-(1-12) and angiotensin I in Wistar Kyoto rats.  HYPERTENSION. Vol. 52, no. 4. (October 1).
  • 2008. Renin-independent processing of angiotensin-(1-12) in the rat heart and isolated myocytes.  HYPERTENSION. Vol. 52, no. 4. (October 1).
  • 2008. New angiotensins.  JOURNAL OF MOLECULAR MEDICINE-JMM. Vol. 86, no. 6. (June 1).
  • 2008. Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats.  AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. Vol. 294, no. 6. (June 1).
  • 2008. Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart.  AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. Vol. 294, no. 5. (May 1).
  • 2008. Experimental Hypertension is Associated with Differential Expression of Angiotensin-(1-12) in Heart of Hypertensive and Normotensive Rats.  FASEB JOURNAL. Vol. 22, no. April 1.
  • Jessup,Jewell,A; Habibi,Javad; Trask,Aaron,J; Chappell,Mark,C; Nagata,Sayaka; Kato,Johji; Kitamura,Kazuo; Sowers,James,R; Ferrario,Carlos,M. 2008. Experimental Hypertension is Associated with Differential Expression of Angiotensin-(1-12) in Heart of Hypertensive and Normotensive Rats.  FASEB JOURNAL. Vol. 22, no. April.
  • Ferrario CM, Jessup JA, Trask AJ, Varagic J. 2008. Basic Science in Hypertension. In The Year in Hypertension. Edited by Townsend R.
  • Ferrario CM, Jessup JA, Trask AJ, Varagic J. 2008. Basic Science in Hypertension. In The Year in Hypertension. Edited by Townsend R. Oxford: Clinical Publishing.
  • Trask, A. J., Jessup, J. A., Chappell, M. C., Ferrario, C. M. 2008. Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart.  Am J Physiol Heart Circ Physiol. Vol. 294, no. 5. (January): H2242-7. PubMed ID: 18359898
  • Varagic, J., Trask, A. J., Jessup, J. A., Chappell, M. C., Ferrario, C. M. 2008. New angiotensins.  J Mol Med (Berl). Vol. 86, no. 6. (January): 663-71. PubMed ID: 18437333
  • Jessup, J. A., Trask, A. J., Chappell, M. C., Nagata, S., Kato, J., Kitamura, K., Ferrario, C. M. 2008. Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats.  Am J Physiol Heart Circ Physiol. Vol. 294, no. 6. (January): H2614-8. PubMed ID: 18408132
  • Trask,Aaron,J; Ferrario,Carlos,M. 2007. Angiotensin-(1-12) is a precursor for the processing of cardiac tissue angiotensin peptides.  HYPERTENSION. Vol. 50, no. 4. (October): E154-E154.
  • 2007. Angiotensin-(1-12) is a precursor for the processing of cardiac tissue angiotensin peptides.  HYPERTENSION. Vol. 50, no. 4. (October 1).
  • 2007. Major role for angiotensin-converting enzyme 2 in cardiac angiotensin-(1-7) production in the congenic hypertensive mRen2.Lewis rat.  HYPERTENSION. Vol. 50, no. 4. (October 1).
  • Trask,Aaron,J; Chappell,Mark,C; Ferrario,Carlos,M. 2007. Major role for angiotensin-converting enzyme 2 in cardiac angiotensin-(1-7) production in the congenic hypertensive mRen2.Lewis rat.  HYPERTENSION. Vol. 50, no. 4. (October): E140-E140.
  • 2007. Angiotensin-(1-7): Pharmacology and new perspectives in cardiovascular treatments.  CARDIOVASCULAR DRUG REVIEWS. Vol. 25, no. 2. (June 1).
  • 2007. Primary role of angiotensin-converting enzyme-2 in cardiac production of anglotensin-(1-7) in transgenic Ren-2 hypertensive rats.  AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. Vol. 292, no. 6. (June 1).
  • Trask, A. J., Ferrario, C. M. 2007. Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments.  Cardiovasc Drug Rev. Vol. 25, no. 2. (January): 162-74. PubMed ID: 17614938
  • Trask, A. J., Averill, D. B., Ganten, D., Chappell, M. C., Ferrario, C. M. 2007. Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats.  Am J Physiol Heart Circ Physiol. Vol. 292, no. 6. (January): H3019-24. PubMed ID: 17308000
  • 2006. Predominance of angiotensin converting enzyme 2 to cardiac angiotensin-(1-7) production in [mRen2]27 transgenic hypertensive rats.  HYPERTENSION. Vol. 48, no. 4. (October 1).
  • Trask,Aaron,J; Averill,David,B; Chappell,Mark,C; Ferrario,Carlos,M. 2006. Predominance of angiotensin converting enzyme 2 to cardiac angiotensin-(1-7) production in [mRen2]27 transgenic hypertensive rats.  HYPERTENSION. Vol. 48, no. 4. (October): E72-E72.
  • 2005. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function.  AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. Vol. 289, no. 6. (December 1).
  • Ferrario, C. M., Trask, A. J., Jessup, J. A. 2005. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function.  Am J Physiol Heart Circ Physiol. Vol. 289, no. 6. (January): H2281-90. PubMed ID: 16055515
  • Delbin, M.A., Trask, A.J. The Diabetic Vasculature: Physiological Mechanisms of Dysfunction and Influence of Aerobic Exercise Training in Animal Models.  Life Sciences.

Awards, Honors and Organizations

  • 2016 APS-TPS Joint Meeting Award, Dublin, Ireland
  • 2015 Junior Faculty Citizenship Award, Department of Pediatrics, The Ohio State University College of Medicine
  • 2014 Elected Fellow, American Heart Association Council for High Blood Pressure Research (Barbara J. Alexander, PhD, FAHA, nominator)
  • 2012 Research Recognition Award, Cardiovascular Section, American Physiological Society
  • 2012 Best Poster Award – Postdoctoral Fellow Category, The Research Institute at Nationwide Children’s Hospital Research Day
  • 2010 Caroline tum Suden/Frances A. Hellebrandt Professional Opportunity Award, American Physiological Society
  • 2010, American Physiological Society Logo Design Award Winner
  • 2009 WFU Department of Physiology & Pharmacology Sundberg Memorial Award
  • 2009 Marquis Who’s Who Among Executives and Professionals
  • 2008 Merck New Investigator Award, American Heart Association Council for High Blood Pressure Research
  • 2007 American Heart Association Hypertension Summer School Travel Award
  • 2006-2007 Wake Forest University Graduate School Alumni Travel Award
  • 2000-2003 Ohio Northern University Arts & Sciences Scholarship
  • 1999-2003 Ohio Northern University Dean’s List
  • 1999-2003 Ohio Northern University Achievement/Leadership Award Scholarship
  • 1999 Ohio Northern University Dean’s Scholarship
  • 1999 Tiffany Furgason Memorial Scholarship
  • 1999 Arcanum Alumni Scholarship
  • Professional Affiliations:

    2013-Present: Microcirculatory Society

    2011-Present: American Association for the Advancement of Science

    2009-Present: American Society for Pharmacology and Experimental Therapeutics Division of Cardiovascular Pharmacology (2009-2012 Public Relations/Communications Committee; 2016-2017: Executive Committee; 2016-2019: Benedict R. Lucchesi Young Scientist Award Committee)

    2005-Present: American Heart Association Council on Hypertension (2009-2013: Member, Trainee Advocacy Committee; 2013-2016: Chair, Trainee Advocacy Committee; 2013-2016: Member, Leadership Committee; 2015: Programming Committee)

    2014-2015: American Heart Association National Committee on Committees, Early Career Subcommittee

    June 2014: American Heart Association Scientific Meetings Summit Invitee/Participant

    2005-Present: American Physiological Society (APS), Cardiovascular Section (2009-2012: NIH-NHLBI Liaison Committee; 2012-2015: Awards Committee; 2016-2019: Nominating Committee [Elected])

    2005-Present: Consortium for Southeastern Hypertension Control

    2001-Present: Beta Beta Beta National Biology Honor Society

    2001-Present: Omicron Delta Kappa National Leadership Honor Society
  • Institutional Organizations/Activities:

    2013-Present: Faculty Representative, Finance and Sponsored Projects Advisory Group, Nationwide Children's Hospital

    2009-2013: Founding Member, Nationwide Children's Hospital Postdoctoral Association

    2006 Student Member, Wake Forest University Department of Physiology and Pharmacology Curriculum Committee

    2004-2008 Student Member, Wake Forest University Graduate Student Association

    2001-2003 Chairman, Judicial Board, Ohio Northern University

    2000-2003 Chairman, Judicial Committee, Ohio Northern University Student Senate
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000